FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today reported that it has received zero accounts of erosion of the aortic root or the free wall of the atrium associated with the worldwide use of the GORE® HELEX® Septal Occluder. The positive data comes from more than a decade of clinical experience using the Gore Device. Encouraging news for the thousands of patients treated with the GORE HELEX Septal Occluder to close the genetic condition of atrial septal defect (ASD), an abnormal hole in the wall between the heart’s upper chambers. Leading cardiologists with experience using the Gore Device credit the expanded polytetrafluorethylene (ePTFE) material, a biocompatible material that allows tissue ingrowth to seal the defect.
